Over the past week, we have seen five CEOs report insider buys costing them over $100,000. These buys can be significant to note because CEOs are expected to have the most knowledge about their companies and would likely only invest their own money if they expect the share price to rise.
Royal Caribbean Cruises (RCL)
Chairman and CEO Richard Fain has made the largest insider buy this week, buying nearly one million dollars worth of shares.
Richard Fain added 26,800 shares to his stake on July 29. The insider purchased these shares at an average price of $36.82 per share. This transaction cost the CEO a total of $986,776. Since his purchase, the price per share has increased approximately 1.6%. Fain now holds on to nearly 1.5 million shares of Royal Caribbean.
Fain�� most recent insider transaction is the first insider buy since Aug. 2011.
Royal Caribbean Cruises is a global cruise vacation company that operates Royal Caribbean International, Celebrity Cruises, Pullmantur, Azamara Cruises and CDF Croisieres de France. The company also offers land-tour vacations in Alaska, Asia, Australia, New Zealand, Canada, Europe and South America.
Royal Caribbean�� historical price, revenue and net income:
[ Enlarge Image ]
The company�� most recent quarterly results highlighted:
路 Net income of $24.7 million, or $0.11 per share, compared to a net loss of $3.7 million in the second quarter 2012.
路 Expects the full-year EPS to be in the range of $2.20 to $2.30.
路 Made $1.4 million in passenger ticket revenues.
路 Lost $0.05 per share as a result of the Grandeur fire.
The analysis on the company reports that the company has issued $489.992 million of debt over the past three years. It also notes that the company�� revenue has slowed down over the past year, that the price is nearing a 1-year high and that the P/S ratio is nearing a 2-year high.
Royal Caribbean has a market cap of $8.1 billion. Its shares are c! urrently traded at around $37.41 with a P/E ratio of 108.50, a P/S ratio of 1.00 and a P/B ratio of 1.00. The company had an annual average earnings growth of 2.2% over the past ten years.
There are currently 12 gurus that hold a position in Royal Caribbean. Click here to see their holding histories.
Winmark Corporation (WINA)
Chairman and CEO John Morgan of Winmark Corporation made a notable buy on July 29. The CEO purchased 2,000 shares at approximately $68.55 per share. This transaction cost the CEO $137,100. Since his most recent buy, the price per share has increased approximately 5.56%. Morgan currently holds over 1.7 million shares of Winmark.
This insider buy comes as the share price continues to exceed past the company�� 10-year high price.
Winmark is a franchisor of five retail store concepts that buy, sell, trade and consign merchandises. The five stores include: Play It Again Sports, Once Upon a Child, Plato�� Closet, Music Go Round and Style Encore. Style Encore is Winmark�� most recent concept, and the company recently announced the signing of Style Encore�� franchise agreements.
Winmark�� historical price, revenue and net income:
[ Enlarge Image ]
The company�� second quarter results reported:
路 Net income of $4,336,900, or $0.83 per diluted share, up from $3.4 million last year.
路 An additional 67 retail franchises have been awarded but are not open yet.
路 The company�� lease portfolio is up to $37.2 million.
路 Free cash flow of $2.04 million, down from $2.23 million at the close of 2012.
The Peter Lynch Chart shows that Winmark appears to be overvalued:
[ Enlarge Image ]
Winmark has a market cap of $375 million. Its shares are currently being traded at around $72.36 with a P/E ratio of 26.20, a P/S ratio of 6.80 and a P/B ratio of 13.20. The company had an annual average earnings growth of 24.5% over the past ten years.
Jim Simons is the only guru that maintains a! position! in Winmark. He holds 55,400 shares representing 1.11% of the company�� shares outstanding.
Phillips 66 Partners LP (PSXP)
Chairman and CEO Greg Garland made a significant buy during the company�� IPO on July 26. Garland purchased 35,000 shares at $23 per share. This transaction cost him a total of $805,000.
During the IPO, seven other insiders made buys. These insiders consisted of CFO Gregory Maxwell, President Timothy Taylor, VP of Investor Relations Craig Clayton, VP and COO J.T. Liberti, VP and Controller Charles Johnson, Director Mark Haney and Director Joseph O��oole. These insiders bought a total of 187,500 shares at $23 per share. These buys cost the insiders a cumulative total of $4,312,500.
Phillips 66 Partners is a growth-oriented, traditional master limited partnership recently formed by Phillips 66 to own, operate, develop and acquire primarily fee-based crude oil, refined petroleums and natural gas liquids, pipelines and terminals and other transportation and midstream assets.
Since the IPO, the share price has increased by 38.09%
There are currently no gurus that hold a position in Phillips 66 Partners.
Solitario Exploration & Royalty (XPL)
Several insiders made significant buys this week as the company�� share price continues to dwindle beneath its all-time lows. Most notably, President and CEO Christopher Herald bought 400,000 shares. He purchased these shares at $0.84 per share for a total transaction amount of $336,000. Since this buy, the share price has increased approximately 11.9%.
Four other insiders made buys this week. These insiders purchased a total of 206,665 shares at $0.84 per share. These buys cost the insiders a combined total of $173,599.
These buys were as a result of a private placement of 2.45 million shares at $0.84 per share, and marked the lowest share price Solitario has seen since 2011. These buys also mark the first insider buys for the company since June 2012.
! Solitario! is a gold, silver, platinum-palladium and base metal exploration, development and royalty company that is actively exploring in Brazil, Mexico, Peru and Nevada.
Solitario�� historical price, revenue and net income:
[ Enlarge Image ]
The analysis on Solitario Exploration & Royalty reports:
路 Revenue has been in a decline over the past year.
路 The company is having difficulty collecting payments.
路 The operating margin has been in a 5-year decline.
路 The price is currently sitting near a 10-year low.
Solitario Exploration & Royalty has a market cap of $31.9 million. Its shares are currently being traded at around $0.94 with a P/S ratio of 107.60 and a P/B ratio of 3.80. The company had an annual average earnings growth of 2.7% over the past five years.
Guru Robert Bruce holds 254,040 shares of Solitario representing 0.73% of the company�� shares outstanding.
Alexza Pharmaceuticals (ALXA)
As Alexza Pharmaceuticals��price has continued to stay at a 10-year low price, President and CEO Thomas King decided to increase his holdings in the company.
King purchased 40,000 shares of his company�� stock at $4.48 per share. This transaction cost the CEO a total of $179,200. Since his buy, the price per share has increased approximately 4.24%. King now holds a total of 245,823 shares of company stock.
King�� buy marks the first insider buy since Dec. 2012.
Alexza Pharmaceuticals is focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions, including agitation, acute repetitive seizures and insomnia.
Alexza�� historical price, revenue and net income:
[ Enlarge Image ]
The company is set to release their second quarter financial results on August 8, 2013.
The analysis on the company reports:
路 The company displays signs of poor business operation.
路 The revenue has been in decline! over the! past three years.
路 The P/S ratio is near a 2-year high of 22.32.
Alexza Pharmaceuticals has a market cap of $74 million. Its shares are currently being traded at around $4.67 with a P/S ratio of 22.50.
There are currently no gurus that maintain positions in Alexza Pharmaceuticals.
You can view all CEO buys and sells here. Also, check out the new Canadian Insider Trade Page.
Try a free 7-day Premium Membership Trial here.
Top 10 Low Price Companies To Buy Right Now: Cathay Intl(CTI.L)
Cathay International Holdings Limited, an investment holding company, operates primarily in the healthcare sector. It engages in the manufacturing, marketing, and sale of specialty western pharmaceuticals, modern Chinese medicine extracts, and generic pharmaceuticals in the People?s Republic of China; manufacturing, marketing, and sale of plant extracts for use as active ingredients in food, beverages, cosmetics, dietary supplements, and healthcare products; and the development of pharmaceutical products. The company also operates Crowne Plaza Landmark Hotel & Suites Shenzhen, a five star business traveler hotel in the Lowu district of Shenzhen, the People?s Republic of China. Cathay International Holdings Limited is based in Central, Hong Kong.
Top 10 Low Price Companies To Buy Right Now: Zena Mining Corp (ZCC.V)
Zena Mining Corp., an exploration stage company, engages in the exploration and development of industrial minerals, including barite in British Columbia, Canada. It holds 100% mineral rights in properties consisting of 9 claims covering 300 hectares situated in the Greenwood mining division of British Columbia near the town of Rock Creek. The company was formerly known as Zena Capital Corp. and changed its name to Zena Mining Corp. in June 2009. Zena Mining Corp. was founded in 2000 and is based in Vancouver, Canada.
United Bancshares, Inc. operates as a bank holding company for The Union Bank Company that engages in the provision of commercial banking services to small and middle-market businesses and individuals. It accepts various deposit products, including checking accounts, savings and money market accounts, time certificates of deposit, time deposits, and demand deposits. The company also offers various loan products that consist of commercial, consumer, agricultural, residential mortgage, and home equity loans. In addition, it provides automatic teller machine services, safe deposit box rentals, and other personalized banking services. The company serves primarily in the Ohio counties of Allen, Hancock, Putnam, Sandusky, Van Wert, and Wood, as well as with office locations in Bowling Green, Columbus Grove, Delphos, Findlay, Gibsonburg, Kalida, Leipsic, Lima, Ottawa, and Pemberville, Ohio. United Bancshares, Inc. was founded in 1904 and is headquartered in Columbus Grove, Ohio.< /p>
Top 10 Low Price Companies To Buy Right Now: SMG ORD GBP0.50(STVG.L)
STV Group plc engages in the production and broadcasting of television programmes in the United Kingdom and internationally. The company also provides Internet services; sells advertising airtime and space in these media; creates and produces content for broadcast networks; and offers content in various platforms, including digital terrestrial, cable and satellite, online, and connected devices for advertisers to attract mass audiences. In addition, it operates digital channels and Website stv.tv, which offer news, sport, and entertainment; STV Player that provides STV programmes; and STV Local, a network of hyper-local Websites. STV Group plc is headquartered in Glasgow, the United Kingdom.
Top 10 Low Price Companies To Buy Right Now: Saratoga Electronic Solutions I (SAR.V)
Saratoga Electronic Solutions Inc. engages in placing and operating a network of automated teller machines (ATMs) primarily in eastern Canada. It also involves in the wholesale distribution of prepaid cards, point-of-sale activated prepaid phone personal identification numbers (P.O.S.A.), prepaid debit cards, long distance calling cards, and various electronic gift card solutions to consumers. The company provides its prepaid products through freestanding intelligent machines, P.O.S.A. terminals, and traditional merchants. As of March 31, 2011, it operated a network of approximately 445 ATMs, as well as managed approximately 2,670 point-of-sale locations. The company was founded in 2005 and is based in Montreal, Canada.
Top 10 Low Price Companies To Buy Right Now: YRC Worldwide Inc.(YRCW)
YRC Worldwide Inc., through its subsidiaries, provides various transportation services worldwide. The company?s YRC National Transportation unit offers a range of services for the transportation of industrial, commercial, and retail goods, such as apparel, appliances, automotive parts, chemicals, food, furniture, glass, machinery, metal, metal products, non-bulk petroleum products, rubber, textiles, wood, and other manufactured products. It serves manufacturing, wholesale, retail, and government customers. As of December 31, 2009, it had 11704 owned tractors, 1239 leased tractors, 50083 owned trailers, and 3244 leased trailers. Its YRC Regional Transportation unit?s service portfolio includes regional delivery, which comprises next-day local area delivery and second-day services, consolidation/distribution services, protect-from-freezing and hazardous materials handling, and various specialized offerings; expedited delivery, that comprises day-definite, hour-definite, and time definite capabilities; inter-regional delivery; cross-border delivery; and operation of my.yrcregional.com and NewPenn.com, which are e-commerce Websites offering online resources to manage transportation activity. The company?s YRC Logistics units? service portfolio consists of distribution services that include flow through and pool distribution, dedicated warehousing, and value-added services; global services, which comprise international freight forwarding, customs brokerage, and value-added services; and transportation services, such as truckload brokerage, domestic freight forwarding, and transportation management. Its YRC Truckload unit provides customized truckload services on regional and national level through the use of company and team-based drivers. The company was founded in 1924 and is headquartered in Overland Park, Kansas.
Top 10 Low Price Companies To Buy Right Now: Biogen Idec Inc(BIIB)
Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t he treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer's disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.
Advisors' Opinion: - [By Ken Sweet]
Biogen Idec (BIIB), a maker of specialized treatments for neurological diseases like multiple sclerosis, benefited from two positive developments in its drug pipeline this year.
In April, the company announced positive results from a Phase 3 clinical trial for a new MS treatment called BG-12. Phase 3 trials are often the last step in a drug's development before it heads to market.
Later that month, the Food and Drug Administration approved the drug Rituxan, which Biogen co-developed with Roche's (RHBBY) Genentech, for use in treating two extremely rare diseases -- Wegener's Granulomatosis and Microscopic Polyangiitis.The combination of those two events sent shares of Biogen up more than 30% in April alone.
Top 10 Low Price Companies To Buy Right Now: PIMCO Municipal Income Fund III(PMX)
PIMCO Municipal Income Fund III is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Co LLC. It invests in fixed income markets. The fund invests in a portfolio of municipal bonds, including long and short U.S. Treasury Notes, and U.S. Treasury Bond Futures. PIMCO Municipal Income Fund III was formed in 2002 and is domiciled in United States.
Top 10 Low Price Companies To Buy Right Now: Canada Fluorspar Inc (CFI.V)
Canada Fluorspar Inc., a specialty mineral resource company, engages in the development and production of fluorspar deposits in Canada. It holds a 100% interest in the St. Lawrence Fluorspar project, which consists of six mineral licenses located in St. Lawrence, Newfoundland and Labrador. The company is headquartered in St. John�s, Canada.
Top 10 Low Price Companies To Buy Right Now: Exoma Energy Ltd (EXE.AX)
Exoma Energy Limited engages in the exploration of oil and gas properties in Australia. The company explores for conventional oil, shale oil, and gas and coal seam gas contained in coal and carbonaceous shales. Exoma Energy Limited holds a 50% interest in 5 exploration permits covering an area of approximately 27,000 square kilometers of the Eromanga and Galilee Basins in Central Queensland. The company is headquartered in Brisbane, Australia.